Diligence memo · auto-generated · as of July 3, 2026

Oliver Street Dermatology Holdings LLC

Oliver Street Dermatology Holdings LLC looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Oliver Street Dermatology Holdings LLC operates in Other Health Care, based in BOSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Oliver Street Dermatology Holdings LLC has raised $110M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $58M on 2014-04-22.

Most recent recorded round closed around 2016-04-01.

Valuation (modeled)modeled

Provath models Oliver Street Dermatology Holdings LLC at approximately $13M (range $2.1M–$35M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.01× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 6 months.

Last raise 10.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 96% of Other Health Care peers (5377 compared).

Modeled value ranks above 40% of those peers.

Closest niche peers: Specialty Networks, LLC, New MMI Holdings, Inc., BioMatrix Holdings, L.L.C., Sea Hunter Holdings, LLC, Bind Benefits, Inc..

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.